IDT Biologika

Bild durch Klicken auf Symbol hinzufügen

2016

IDT BiologikaBiologics for the 21st century

2IDT Biologika Corporate Presentation

IDT Biologika, Dessau SiteIntegrated pharma- and biotechnology

3IDT Biologika Corporate Presentation

Vaccines and biologic parenteralsIDT Biologika – Two business models

Contract manufacturingDevelopment, industrialization and production of prophylactic and therapeutic products using highly efficient manufacturing technologiesLong-term international technology and manufacturing partnerships

Animal HealthInnovative, groundbreaking solutions to fight infectious diseases in animalsOwn products are marketed worldwide

4IDT Biologika Corporate Presentation

The company in facts and figures

OwnersHartmut, Carsten and Stefan Klocke via the Klocke Group

RatingInvestment Grade

8%of revenue

dedicated to research &

development

+ €200 million

revenues in 2016

1,700employees in

2016

€300 millioninvested by IDT

since 1993, €100 million between 2011 and today

WorldwideIDT works with

customers/partners around the

world

5IDT Biologika Corporate Presentation

Development of Revenues and Staff Staff Revenues

€ millionA corporate strategy with a focus on globalization and industrialization forms the basis for further growth

IDT Biologika

Thank you for your attention

2016